QTRX insider trading
NasdaqGM HealthcareQuanterix Corp: insider trade history from SEC Form 4 filings.
About Quanterix Corp
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Company website: www.quanterix.com
QTRX insider activity at a glance
FilingIQ tracks 1,202 insider transactions for QTRX in filings since Dec 11, 2017. The most recent transaction is dated Oct 2, 2026.
Across the full history, 29 open-market purchases
and 554 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on QTRX insider trades is 58.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest QTRX Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading QTRX
Frequently asked
- How many insider trades does FilingIQ track for QTRX?
- FilingIQ tracks 1,202 Form 4 insider transactions for QTRX (Quanterix Corp), covering filings from Dec 11, 2017 onwards. 41 of those are dated within the last 90 days.
- Are QTRX insiders net buyers or net sellers?
- Across the full Form 4 history for QTRX, 29 transactions (2%) were open-market purchases and 554 (46%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does QTRX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is QTRX in?
- Quanterix Corp (QTRX) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $269.52M.
Methodology & sources
Every QTRX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.